Search all trials

Find therapies in clinical trials near you – page 9

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Hidradenitis

Not recruiting

Investigational

Study of Lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa

Investigational

Ireland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Lutikizumab

Contact Research Centre

Malignant peritoneal neoplasm+2

Not recruiting

Registered drug

Study of Rucaparib and Nivolumab for Maintenance Treatment in Patients with Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer After Chemotherapy

Registered drug

Ireland

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Non-small cell lung cancer metastatic

Not recruiting

Registered drugNo placebo

Study Comparing Ceralasertib and Durvalumab with Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer After Previous Treatments

Registered drugNo placebo

Ireland

Participants:18–64 years · 65+ years
Substances:Ceralasertib

Contact Research Centre

Bladder transitional cell carcinoma

Not recruiting

Registered drug

Study on Atezolizumab for Patients with High-Risk Muscle-Invasive Bladder Cancer with Positive ctDNA After Surgery

Registered drug

Ireland

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Gastric cancer

Not recruiting

Registered drug

Study of Bemarituzumab and Chemotherapy for Patients with Advanced Stomach or Gastroesophageal Cancer with FGFR2b Overexpression

Registered drug

Ireland

Participants:18–64 years · 65+ years
Substances:Bemarituzumab

Contact Research Centre

Endometrial cancer

Not recruiting

Registered drugNo placebo

Study on MK-2870 for Patients with Endometrial Cancer After Platinum and Immunotherapy Treatment

Registered drugNo placebo

Ireland

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Myelofibrosis+1

Not recruiting

Registered drug

Study on Luspatercept for Treating Anemia in Adults with Myelofibrosis on JAK2 Inhibitor Therapy Requiring Red Blood Cell Transfusions

Registered drug

Ireland

Participants:18–64 years · 65+ years
Substances:Luspatercept

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drug

Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma

Registered drug

Ireland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Cemiplimab

Contact Research Centre

Monkeypox+1

Not recruiting

Registered drugNo placebo

Study on the Effectiveness of Modified Vaccinia Ankara Vaccine in Preventing Mpox Infection in Adults

Registered drugNo placebo

Ireland

Participants:18–64 years
Substances:Modified Vaccinia Ankara – Bavarian Nordic Live Virus

Contact Research Centre

K-ras gene mutation+1

Not recruiting

InvestigationalNo placebo

Study of adagrasib in elderly patients (70 years or older) or patients with poor performance status who have KRAS G12C mutation-positive non-small cell lung cancer

InvestigationalNo placebo

Ireland

Participants:18–64 years · 65+ years
Substances:Adagrasib

Contact Research Centre

Gastrooesophageal cancer+5

Not recruiting

Registered drug

Study of Nivolumab or Placebo for Patients with Removed Esophageal or Gastroesophageal Junction Cancer

Registered drug

Ireland

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study on Alnuctamab and Drug Combination for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Ireland

Participants:18–64 years · 65+ years
Substances:Alnuctamab

Contact Research Centre

Find therapies in clinical trials near you – page 9

157 trials match your criteria

Hidradenitis

Study of Lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa

Malignant peritoneal neoplasm+2

Study of Rucaparib and Nivolumab for Maintenance Treatment in Patients with Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer After Chemotherapy

Non-small cell lung cancer metastatic

Study Comparing Ceralasertib and Durvalumab with Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer After Previous Treatments

Bladder transitional cell carcinoma

Study on Atezolizumab for Patients with High-Risk Muscle-Invasive Bladder Cancer with Positive ctDNA After Surgery

Gastric cancer

Study of Bemarituzumab and Chemotherapy for Patients with Advanced Stomach or Gastroesophageal Cancer with FGFR2b Overexpression

Endometrial cancer

Study on MK-2870 for Patients with Endometrial Cancer After Platinum and Immunotherapy Treatment

Myelofibrosis+1

Study on Luspatercept for Treating Anemia in Adults with Myelofibrosis on JAK2 Inhibitor Therapy Requiring Red Blood Cell Transfusions

Malignant melanoma

Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma

Monkeypox+1

Study on the Effectiveness of Modified Vaccinia Ankara Vaccine in Preventing Mpox Infection in Adults

K-ras gene mutation+1

Study of adagrasib in elderly patients (70 years or older) or patients with poor performance status who have KRAS G12C mutation-positive non-small cell lung cancer

Gastrooesophageal cancer+5

Study of Nivolumab or Placebo for Patients with Removed Esophageal or Gastroesophageal Junction Cancer

Plasma cell myeloma

Study on Alnuctamab and Drug Combination for Patients with Relapsed or Refractory Multiple Myeloma

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.